$LIT Watch: Up 6.2%, driven by expectations of a CFTC application—the application itself has not yet been submitted
LIT is currently at $3.49, up 6.19% in 24 hours, with a high of $3.57 and trading volume of $17.9 million
This rally began on October 21, when the Lighter founder said on a third-quarter investor call that the company would apply to the CFTC in November for two licenses: a designated contract market (DCM) and a derivatives clearing organization (DCO). LIT rose 21% that day
As of today, the application has not been submitted, and no approvals have been granted. Under the CFTC framework, the review period is about 180 days, so the earliest a decision could come is spring 2027
Buybacks are another factor supporting the price: Lighter spent about $4.1 million buying back LIT in October
The pressure point is December 27, when team and investor allocations begin to unlock. Of the 1 billion total supply, about 250 million are circulating, while roughly three-quarters remain locked or in reserve. Before regulatory approval comes through, the first thing to watch is whether the application is submitted on schedule.
LIT is currently at $3.49, up 6.19% in 24 hours, with a high of $3.57 and trading volume of $17.9 million
This rally began on October 21, when the Lighter founder said on a third-quarter investor call that the company would apply to the CFTC in November for two licenses: a designated contract market (DCM) and a derivatives clearing organization (DCO). LIT rose 21% that day
As of today, the application has not been submitted, and no approvals have been granted. Under the CFTC framework, the review period is about 180 days, so the earliest a decision could come is spring 2027
Buybacks are another factor supporting the price: Lighter spent about $4.1 million buying back LIT in October
The pressure point is December 27, when team and investor allocations begin to unlock. Of the 1 billion total supply, about 250 million are circulating, while roughly three-quarters remain locked or in reserve. Before regulatory approval comes through, the first thing to watch is whether the application is submitted on schedule.
